FDA NDC Directory · JSON-LD · Markdown

HYRIMOZ

NDC 83457-113 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameadalimumab-adaz
Labeler / ManufacturerCordavis Limited
Marketing categoryBiologic License Application · App BLA761071
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsADALIMUMAB (80 mg/.8mL)
Marketing started20231215
Package count1

External sources

Source: openFDA. Public-domain (CC0).